NVA237 Versus Placebo 12-week Efficacy Study

PHASE3CompletedINTERVENTIONAL
Enrollment

440

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

NVA237

NVA237 (glycopyrronium bromide) as a powder for inhalation in single-dose capsules.

DRUG

Placebo

Placebo powder for inhalation in single-dose capsules (matching those for NVA237).

Trial Locations (54)

27607

Novartis Investigative Site, Raleigh

28152

Novartis Investigative Site, Shelby

28207

Novartis Investigative Site, Charlotte

29201

Novartis Investigative Site, Columbia

29303

Novartis Investigative Site, Spartanburg

29340

Novartis Investigative Site, Gaffney

29379

Novartis Investigative Site, Union

29407

Novartis Investigative Site, Charleston

29615

Novartis Investigative Site, Greenville

29640

Novartis Investigative Site, Easley

29666

Novartis Investigative Site, Ninety Six

29678

Novartis Investigative Site, Seneca

29681

Novartis Investigative Site, Simpsonville

29732

Novartis Investigative Site, Rock Hll

32127

Novartis Investigative Site, Port Orange

32132

Novartis Investigative Site, Edgewater

32435

Novartis Investigative Site, DeFuniak Springs

32503

Novartis Investigative Site, Pensacola

32789

Novartis Investigative Site, Winter Park

33012

Novartis Investigative Site, Hialeah

33060

Novartis Investigative Site, Pompano Beach

33136

Novartis Investigative Site, Miami

33143

Novartis Investigative Site, South Miami

33156

Novartis Investigative Site, Miami

33173

Novartis Investigative Site, Miami

33186

Novartis Investigative Site, Miami

33306

Novartis Investigative Site, Fort Lauderdale

33321

Novartis Investigative Site, Tamarac

33511

Novartis Investigative Site, Brandon

33603

Novartis Investigative Site, Tampa

33756

Novartis Investigative Site, Clearwater

34233

Novartis Investigative Site, Sarasota

34491

Novartis Investigative Site, Summerfield

35501

Novartis Investigative Site, Jasper

75251

Novartis Investigative Site, Dallas

76012

Novartis Investigative Site, Arlington

76014

Novartis Investigative Site, Arlington

76712

Novartis Investigative Site, Waco

77340

Novartis Investigative Site, Huntsville

77701

Novartis Investigative Site, Beaumont

85712

Novartis Investigative Site, Tucson

89104

Novartis Investigative Site, Las Vegas

89123

Novartis Investigative Site, Las Vegas

90048

Novartis Investigative Site, Los Angeles

90095

Novartis Investigative Site, Los Angeles

92120

Novartis Investigative Site, San Diego

92506

Novartis Investigative Site, Riverside

92708

Novartis Investigative Site, Fountain Valley

92835

Novartis Investigative Site, Fullerton

35209-6870

Novartis Investigative Site, Homewood

Unknown

Novartis Investigative Site, *See Various Dept.'s*

92117-4946

Novartis Investigative Site, San Diego

29406-7108

Novartis Investigative Site, Charleston

79106-4165

Novartis Investigative Site, Amarillo

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY